111 Development of artemisinin analogueanalog SM934 in the treatment of systemic lupus erythematosus

J Zuo, W Tang
2017 Poster Session   unpublished
Results Then, anasarca and nephrosis was improved and S-Cr was decreased to 1.20 mg/dL in proportion to the reduction in activated Th17 cells in PD. Conclusions Although recent studies have begun to shed light on the role of IL-17 in the pathogenesis of SLE, there is no convincing evidence in actual patients. In this case, improvement of disease activity of SLE was correlated with the decrease of activated Th17. This is the first report that the IL-17-targeted therapy for SLE was shown to be
more » ... ective in a patient skewing towards Th17-phenotype.
doi:10.1136/lupus-2017-000215.111 fatcat:uw2q5qnaybczzm2u6aq552ojay